Germ cell tumors(n = 81) | Hematological neoplasms(n = 83) | Head and neck cancers(n = 61) | Thoracic tumors(n = 14) | Abdominal tumors(n = 32) | Other Tumors(n = 42) | p-Valuec | |
---|---|---|---|---|---|---|---|
abstinence time(days) a | 4.5 ± 1.9(n = 62,77 %f) | 4.1 ± 1.4(n = 61, 73 %f) | 4.8 ± 2.2(n = 53, 87 %f) | 4.8 ± 2.1(n = 11,79 %f) | 4.4 ± 1.8(n = 24,75 %f) | 4.9 ± 2.0(n = 30,71 %f) | 0.7262d |
volume at banking (mL) a | 3.7 ± 1.5 | 3.2 ± 1.3 | 3.3 ± 1.6 | 3.8 ± 1.3 | 2.7 ± 1.3 | 3.5 ± 1.6 | <0.0001 d |
numbers of samples banked b | 4(1–17) | 4(1–10) | 4(1–20) | 4(2–5) | 4(1–12) | 4(1–8) | 0.5431e |
pre-count (106/mL) b | 26(0.9–159) | 41(0.7–222) | 64(0.4–620) | 47.5(0.4–108) | 64(3.3–229) | 54.5(1.2–226) | 0.0015e |
pre-total sperm number (106) b | 81(3-726) | 157(1-1701) | 215(1-1612) | 173(2-658) | 209(12-1438) | 149(4-710) | < 0.0001e |
pre-progressive motility (%) b | 48.5(3.1–83) | 48(1.04-75) | 51.5(4–73) | 53(18–79) | 45(8–70) | 50(9–81) | 0.2334e |
post-count (106/mL) b | 16.5(0.6–89) | 28(0.5–120) | 42(3.7–193) | 23(0.3–52) | 40(2.2–120) | 37(0.6–148) | 0.0041e |
post-progressive motility (%) b | 29(0.66-61) | 29(2–60) | 30.5(8–64) | 23(6–55) | 23(3–45) | 30(0.7–66) | 0.4099e |
recovery rates (%) b | 58.8(2.2–89.6) | 60(9.1–89.6) | 62.4(12.1–89.3) | 52.5(31.9–73.3) | 59(15.2–80.4) | 59.3(2.8–89.2) | 0.8639e |